Semigran Marc - Dec 30, 2022 Form 4 Insider Report for Edgewise Therapeutics, Inc. (EWTX)

Role
Chief Development Officer
Signature
/s/ John R. Moore, Attorney-in-Fact for Semigran Marc
Stock symbol
EWTX
Transactions as of
Dec 30, 2022
Transactions value $
$0
Form type
4
Date filed
1/3/2023, 03:44 PM
Previous filing
Dec 22, 2022
Next filing
Aug 18, 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction EWTX Stock Option (Right to Buy) Award $0 +300K $0.00 300K Dec 30, 2022 Common Stock 300K $8.94 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 1/4th of the shares subject to the option become vested and exercisable on December 19, 2023 and 1/48th of the shares subject to the option continue to vest each month, subject to the Reporting Person continuing as a service provider through each vest date.